INTENSITY THERAPEUTICS, INC.
Data quality: 83%
INTS
Nasdaq
Manufacturing
Chemicals
$5.57
▲
$0.07
(1.25%)
Mkt Cap: 14.15 M
Price
$5.57
Mkt Cap
14.15 M
Day Range
$5.51 — $5.75
52-Week Range
$4.63 — $50.00
Volume
8,711
Open $5.63
50D / 200D Avg
$7.43
25.08% below
50D / 200D Avg
$8.41
33.78% below
Quick Summary
Key Takeaways
Negative free cash flow of -9.23 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-246.78%
Below sector avg (-51.02%)
ROIC-197.29%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio3.60
Interest CoverageN/A
Valuation
PE (TTM)
-1.22
Above sector avg (-1.98)
P/B Ratio1.96
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.2 | -2.0 |
| P/B | 2.0 | 5.1 |
| ROE % | -246.8 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -11.61 M |
| ROE | -246.78% | ROA | -165.47% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -9.23 M |
| ROIC | -197.29% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 3.60 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 5.91 M | Tangible Book Value | 7.22 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.22 | Forward P/E | N/A |
| P/B Ratio | 1.96 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -65.26% | ||
| Market Cap | 14.15 M | Enterprise Value | 7.08 M |
| Per Share | |||
| EPS (Diluted TTM) | -8.56 | Revenue / Share | N/A |
| FCF / Share | -3.63 | OCF / Share | -3.63 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 79.55% |
| SBC-Adj. FCF | -11.27 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -11.61 M | -16.27 M | -10.54 M |
| EPS (Diluted) | -8.56 | -1.17 | -1.38 |
| Gross Profit | — | — | — |
| Operating Income | -11.97 M | -16.59 M | -8.32 M |
| EBITDA | — | — | — |
| R&D Expenses | 6.79 M | 10.50 M | 4.79 M |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | — | 0.0 | 305,000.0 |
| Income Tax | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 14.10 M | 4.78 M | 17.30 M |
| Total Liabilities | 2.23 M | 1.87 M | 4.13 M |
| Shareholders' Equity | 11.88 M | 2.92 M | 13.16 M |
| Total Debt | — | — | — |
| Cash & Equivalents | 11.92 M | 2.59 M | 8.56 M |
| Current Assets | 12.71 M | 3.36 M | 15.46 M |
| Current Liabilities | 2.15 M | 1.76 M | 3.96 M |
{"event":"ticker_viewed","properties":{"ticker":"INTS","listing_kind":"stock","pathname":"/stocks/ints","exchange":"Nasdaq","country":"US"}}